Guardant Health Inc Asset Resilience Ratio
Guardant Health Inc asset resilience ratio. Guardant Health Inc (GH) has an Asset Resilience Ratio of 5.92% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See GH days of operational coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Guardant Health Inc (2016–2025)
Asset resilience ratio of Guardant Health Inc from 2016 to 2025. This chart shows how Guardant Health Inc's Asset Resilience Ratio has changed over time. Read Guardant Health Inc total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Guardant Health Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see total assets of Guardant Health Inc.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $113.47 Million | 5.92% |
| Total Liquid Assets | $113.47 Million | 5.92% |
Asset Resilience Insights
- Limited Liquidity: Guardant Health Inc maintains only 5.92% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Guardant Health Inc Industry Peers by Asset Resilience Ratio
Compare Guardant Health Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Revvity Inc.
NYSE:RVTY |
Diagnostics & Research | 0.00% |
|
Guangzhou Kingmed Diagnostics Group Co Ltd
SHG:603882 |
Diagnostics & Research | 0.14% |
|
Vijaya Diagnostic Centre Limited
NSE:VIJAYA |
Diagnostics & Research | 15.15% |
|
Sonic Healthcare Ltd
AU:SHL |
Diagnostics & Research | 0.13% |
|
Integral Diagnostics Ltd
AU:IDX |
Diagnostics & Research | 0.03% |
|
Australian Clinical Labs Ltd
AU:ACL |
Diagnostics & Research | 4.11% |
|
Healius Ltd
AU:HLS |
Diagnostics & Research | 0.06% |
|
Monash Ivf Group Ltd
AU:MVF |
Diagnostics & Research | 1.60% |
Guardant Health Inc Asset Resilience Ratio by Year (2016–2025)
Guardant Health Inc asset resilience ratio by year from 2016 to 2025. The table below shows the annual Asset Resilience Ratio data for Guardant Health Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 40.89% | $823.39 Million | $2.01 Billion | +19.72pp |
| 2024-12-31 | 21.17% | $314.44 Million | $1.49 Billion | +19.20pp |
| 2023-12-31 | 1.96% | $35.10 Million | $1.79 Billion | -52.05pp |
| 2022-12-31 | 54.01% | $869.58 Million | $1.61 Billion | +34.03pp |
| 2021-12-31 | 19.98% | $440.55 Million | $2.20 Billion | -22.36pp |
| 2020-12-31 | 42.34% | $961.90 Million | $2.27 Billion | +2.91pp |
| 2019-12-31 | 39.43% | $379.57 Million | $962.53 Million | -7.96pp |
| 2018-12-31 | 47.40% | $278.42 Million | $587.40 Million | +3.94pp |
| 2017-12-31 | 43.46% | $149.04 Million | $342.94 Million | -9.44pp |
| 2016-12-31 | 52.90% | $61.66 Million | $116.56 Million | -- |
About Guardant Health Inc
Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally. The company offers Guardant360 CDx test, a liquid biopsy test for tumor mutation profiling; Guardant360 Liquid test, which measures 740+ genes and supports all guideline-recommended biomarkers; Guardant Reveal test, a blood test that utilizes circulating tu… Read more